My Association Login

Serial Medtech Entrepreneur Joins Seroba Life Sciences as VC Partner

Thursday, 6 October 2016

Dublin, Ireland (6 October 2016):  Seroba Life Sciences (Seroba), a leading European venture capital firm focused on investments in the life sciences, today announced the appointment of James (Jim) L. Greene as Partner. 

Jim brings over 29 years of prior medical device industry experience to his new role at Seroba. A serial entrepreneur, Jim has founded and served as CEO for 4 medical device start ups and currently serves as a member of the Wallace Coulter Oversight committee where he participates in the translation of innovative technologies from the Georgia Institute of Technology and from Emory University, Atlanta, Georgia into successful new commercial ventures.  Additionally, he serves as Board Chairman of Novate Medical Limited, Galway, Ireland.

As CEO and Founder of Galway-based start-up, Apica Cardiovascular, Jim developed a port access and closure system for delivering structural heart therapies which achieved CE Mark within 3 years of being established in Ireland, and which was subsequently sold to Thoratec Corporation.  As CEO of APK (Advanced Medical Technologies), Atlanta, Georgia, he developed a platform technology for delivery of mechanical circulatory support systems (LVADS) for congestive heart failure patients. APK was also acquired by Thoratec Corporation.  Previously, as CEO of Mitral Solutions in Fort Lauderdale, Florida, Jim steered the development of an innovative mitral valve repair device from concept through clinical trials, regulatory approval pathway and eventual sale of the company to St. Jude Medical.   

Jim’s earlier VP and Director level positions with Perclose, AVE, Medtronic, and Bioheart provided him with a breadth of knowledge in concept ideation, financing, product development and commercialisation of medical devices in Ireland, U.S. and Europe.  He holds a BA degree from Furman University, Greenville, South Carolina and served as a Captain in the United States military for seven years following graduation.

Speaking about the appointment, Mr. Peter Sandys, Managing Partner at Seroba said “We are delighted to welcome Jim to the Seroba team.  With his medtech operational and entrepreneurial background, his skill-set fits really well with the experience of the other partners.  We have previously worked on opportunities with Jim and were impressed by his high energy and goal-driven approach.  His extensive range of global contacts will also enhance Seroba’s geographic coverage in key life science markets.”

Ends.

For further information, please call Vicky La Touche-Price on +35316334028 or email vickylatoucheprice@seroba-lifesciences.com.

 

About Seroba Life Sciences.

Seroba is a European life sciences venture capital firm.  We are focused on investing in breakthrough healthcare technologies that promise to improve lives and clinical outcomes. 

Headquartered in Dublin, Ireland, we work with some of the world’s best entrepreneurs developing innovative medical devices, diagnostics and therapeutics.

We fund new healthcare opportunities through key value-adding stages from inception through development, clinical evaluation and early commercialisation.  We help our investee companies to grow and we support them through their development journey, helping them to prepare for market launch or for partnering with leading medtech or pharma companies.

Follow our story at www.seroba-lifesciences.com


logo - Twitter